78.3 %Among viremic AYPLHIV at baseline (n = 360) enrolled in Operation Triple Zero (OTZ), the re-suppression rate was 78.3%.
KenyaVIH/sidapublished 2025The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 9 observations
0.319 odds_ratioCarriage of HbSS was associated with reduced monocytosis in children with P. falciparum malaria in Kisumu County, Western Kenya.
Kenyadrépanocytose · paludismepublished 2020BMC infectious diseasesPubMeddocument of 8 observations
A Plasmodium falciparum malaria survey in school children was conducted across eight counties in western Kenya in 2019.
Kenyapaludismeobserved 2019published 2022Antimicrobial agents and chemotherapyeurope_pmcdocument of 5 observations
2.19 infections/person-yearThe cumulative incidence of malaria infections was 2.19 infections per person-year in the control arm.
Kenyapaludismepublished 2020The American journal of tropical medicine and hygienePubMeddocument of 2 observations
30.3 per_100000In Blantyre, Malawi, the age-standardized incidence rate of oesophageal cancer was 30.3 per 100,000 in females between 2004 and 2008.
Kenyaoesophageal cancerobserved 2004–2008published 2015Cancer epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1016/j.canep.2015.01.001
20.4 per_habitatThe high mean density of An. gambiae s.l. was 20.4 in farmland in Kakamega County, western Kenya between March and June 2019.
Kenyapaludismeobserved March and June 2019published 2021Ethiopian journal of health sciencesPubMeddocument of 8 observations
29 parasites/µLAmong afebrile women (n = 392), the geometric-mean parasite density was 29 parasites/µL.
Kenyapaludismepublished 2022The Journal of infectious diseasesPubMeddocument of 13 observations
7.8 %Parasite prevalence by qPCR was 7.8% in Homa Bay during the wet season.
Kenyapaludismeobserved wet seasonpublished 2021BMC infectious diseasesPubMeddocument of 10 observations
20 %Only 20% of women with breast cancer admitted to inpatient hospice in Western Kenya had received surgical treatment for breast cancer.
Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations
98 %At 6 months postpartum, 339 out of 347 (98%) participants in the control group achieved viral suppression (viral load ≤1000 copies/ml).
KenyaVIH/sidaobserved 6 months postpartumpublished 2023Journal of the International AIDS SocietyPubMeddocument of 8 observations
420 patientsBetween 12th February 2013 and 30th July 2014, a total of 420 children under 5 years of age with diarrhea were analyzed for bacterial enteric pathogens.
Kenyadiarrhéeobserved 12th February 2013 to 30th July 2014published 2019African Journal of Health SciencesOpenAlexdocument of 18 observations
Loss to follow-up (LTFU) was defined as no antiretroviral therapy (ART) refill for ≥90 days and no documentation of transfer, death, or treatment cessation in the patient chart.
KenyaVIH/sidaobserved October 1, 2016, to June 30, 2017published 2021AIDS research and human retrovirusesPubMeddocument of 6 observations
77 %In 2020, the national data warehouse had 77% coverage of individuals on antiretroviral therapy compared to the aggregate-level Kenya Health Information System.
KenyaVIH/sidaobserved 2020published 2023BMC medical informatics and decision makingPubMeddocument of 5 observations
56 %46 (56%) first-febrile infections were polyclonal.
Kenyapaludismepublished 2022Malaria journalPubMeddocument of 8 observations
43 %Vaccine efficacy against all episodes of clinical malaria was 43% (95% CI 28-55) in the Fx012-14-26-38 group up to month 50.
Kenyapaludismepublished 2025The Lancet. Global healthPubMeddocument of 9 observations
21 %Among 74,541 individuals who tested negative for HIV, 15,632/74,541 (21%) were assessed to be at elevated HIV risk.
KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations
150 individualsOne hundred and fifty HIV-infected individuals receiving ART were consecutively recruited to participate in the study.
KenyaVIH/sidapublished 2009AIDS research and therapyeurope_pmcdocument of 8 observations
96 %At discharge, favorable outcomes occurred in 96% (N = 25) of patients without a discharge diagnosis of necrotizing fasciitis at Tenwek Hospital.
Kenyanecrotizing fasciitispublished 2020World journal of surgeryPubMeddocument of 8 observations
26.3 %Mtb-specific non-IFN-γ+ responses (IL-2+ and/or TNF+) were more common than IFN-γ+ responses (26.3% vs 10.3%).
Kenyatuberculosepublished 2026The Journal of infectious diseasesPubMeddocument of 4 observations
34.8 %Among 423 HIV-negative Kenyan men who have sex with men and transgender women, 34.8% chose the monthly pill as their most preferred PrEP option when forced to choose.
KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 9 observations
90 %Compliance with no anti-malarial treatment for test-negative patients ranged from 90% to 92% across surveys conducted between 2014 and 2016 in Kenya.
Kenyapaludismeobserved 2014–2016published 2022Malaria journaleurope_pmcdocument of 5 observations
Less than half of the included patients were alive 3 years after a cancer diagnosis for liver cancer in sub-Saharan Africa.
Kenyacarcinome hépatocellulairepublished 2024The Lancet. Global healtheurope_pmcdocument of 12 observations
16 %The prevalence of suicidal ideation was 16% among a rural community sample of 15-19-year-old Kenyan adolescents.
Kenyasuicidal ideationpublished 2021Global public healthPubMeddocument of 3 observations
79 %79% of participants were worried about their ability to afford cancer treatment due to COVID-19.
Kenyacancer (non précisé)published 2022International journal of cancereurope_pmcdocument of 12 observationsDOI 10.1002/ijc.33910
4 %The C469Y mutation declined from 4% in 2022 to 1% in 2023.
Kenyapaludismeobserved 2022published 2025Scientific reportsPubMeddocument of 6 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.